TD Ameritrade Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-177
Closed -$8K 594
2022
Q4
$8K Sell
177
-182
-51% -$7.88K ﹤0.01% 401
2022
Q3
$14K Hold
359
﹤0.01% 352
2022
Q2
$13K Sell
359
-192
-35% -$7.82K ﹤0.01% 408
2022
Q1
$24K Buy
551
+192
+53% +$8.32K ﹤0.01% 404
2021
Q4
$15K Sell
359
-90
-20% -$3.78K ﹤0.01% 444
2021
Q3
$17K Buy
449
+46
+11% +$2.04K ﹤0.01% 402
2021
Q2
$17K Sell
403
-23
-5% -$968 ﹤0.01% 408
2021
Q1
$15K Hold
426
﹤0.01% 426
2020
Q4
$15K Sell
426
-23
-5% -$829 ﹤0.01% 426
2020
Q3
$17K Buy
449
+23
+5% +$886 ﹤0.01% 402
2020
Q2
$15K Sell
426
-3
-0.7% -$108 ﹤0.01% 394
2020
Q1
$14K Sell
429
-74
-15% -$2.89K ﹤0.01% 382
2019
Q4
$23K Buy
503
+342
+212% +$14.3K ﹤0.01% 378
2019
Q3
$7K Sell
161
-29
-15% -$1.23K ﹤0.01% 473
2019
Q2
$8K Buy
190
+24
+14% +$923 ﹤0.01% 426
2019
Q1
$6K Sell
166
-267
-62% -$10.2K ﹤0.01% 418
2018
Q4
$15K Buy
433
+334
+337% +$12.1K ﹤0.01% 313
2018
Q3
$4K Buy
99
+38
+62% +$1.33K ﹤0.01% 413
2018
Q2
$2K Buy
+61
New +$1.84K ﹤0.01% 335

Other funds holding BSX

TD Ameritrade Investment Management's BSX Position: Q1 2023 in Review

TD Ameritrade Investment Management sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 177 shares — an estimated $8K sold.

TD Ameritrade Investment Management first reported a position in BSX in Q2 2018 and held it in 19 quarters. The position peaked at $24K in Q1 2022. 996 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

  • TD Ameritrade Investment Management reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 177 Boston Scientific shares in Q1 2023, an estimated $8K.
  • TD Ameritrade Investment Management first reported a position in Boston Scientific in Q2 2018 and held it in 19 quarters.
  • TD Ameritrade Investment Management's Boston Scientific position peaked at $24K in Q1 2022.
  • 996 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q1 2023, filed 15 May 2023.